Jan 27, 2023 · Life Sciences. We're working on groundbreaking research aiming to revolutionize the field of life sciences. We're solving some of the most important issues humanity faces with artificial intelligence, developing novel and unconventional computing structures, as well as mathematical and computational modeling.

Jan 5, 2023 · Healthcare and Life Sciences. The combination of increasingly powerful computers and AI offers the possibility to be able to detect, diagnose, and cure diseases like never before. At IBM Research, we’re working on creating software and AI systems that can convert reams of health data into useable information for clinicians the world over. Our ...

Technology has tremendous potential to be a primary catalyst for transformation in the healthcare and life sciences industry. Today a convergence of computing revolutions is taking place that will help accelerate the rate of scientific discovery.

Mar 21, 2023 · In late 2021, Cleveland Clinic and IBM entered into a landmark 10-year partnership to use emerging technologies to help crack some of the biggest challenges in healthcare and life sciences. Using a combination of state-of-the-art high-performance hybrid cloud computing, next-generation AI, and quantum computing, the goal was to create a ...

Ajay Royyuru serves as Chief Science Officer for Healthcare & Life Sciences research at IBM. This team, part of Accelerated Discovery mission in IBM Research, is actively pursuing high quality science, developing novel technologies and achieving translational insights across this industry, including areas of cancer, cardiovascular & metabolic ...

Life sciences researchers are under pressure to innovate faster than ever. Big data offer the promise of unlocking novel insights and accelerating breakthroughs. Ironically, although more data are available than ever, only a fraction is being integrated, understood, and analyzed.

Michal has published more than 70 peer-reviewed papers that were cited more than 6400 times according to Google Scholar. She is a member of the iScience Editorial Advisory Board, PlosOne editor, a co-leader of the AI Alliance for drug discovery working group and a board member of the International Network for Life Sciences, AI-LIFE.

Before to joining IBM Research Elise has had a varied career in IBM’s Healthcare and Life Sciences organization working in both the Information Based Medicine and Life Sciences EBOs. Elise worked for NASA for 10 years in the Space Life Sciences research program where she was a project manager for the Life Sciences Data Archive . Elise also ...

I am a Senior Technical Staff Member part of Healthcare and Life Sciences division of IBM Research. With more than two decades of experience spanning finance, healthcare, and AI-driven drug discovery, I have cultivated a multidisciplinary skillset that bridges research, technical architecture, and real-world solutions.

Mar 17, 2022 · Generative models are a powerful tool in AI that’s crossed over into popular culture in recent years. We’ve seen AI tools that can mimic the styles of master painters, videos where an actor’s face is eerily plastered on a video of another actor, and AI systems where a user gives a prompt, for a picture or a short story, and they generate something entirely fictional based on …